Unknown

Dataset Information

0

Early Chronic Memantine Treatment-Induced Transcriptomic Changes in Wild-Type and Shank2-Mutant Mice.


ABSTRACT: Shank2 is an excitatory postsynaptic scaffolding protein strongly implicated in autism spectrum disorders (ASDs). Shank2-mutant mice with a homozygous deletion of exons 6 and 7 (Shank2-KO mice) show decreased NMDA receptor (NMDAR) function and autistic-like behaviors at juvenile [∼postnatal day (P21)] and adult (>P56) stages that are rescued by NMDAR activation. However, at ∼P14, these mice show the opposite change - increased NMDAR function; moreover, suppression of NMDAR activity with early, chronic memantine treatment during P7-21 prevents NMDAR hypofunction and autistic-like behaviors at later (∼P21 and >P56) stages. To better understand the mechanisms underlying this rescue, we performed RNA-Seq gene-set enrichment analysis of forebrain transcriptomes from wild-type (WT) and Shank2-KO juvenile (P25) mice treated early and chronically (P7-21) with vehicle or memantine. Vehicle-treated Shank2-KO mice showed upregulation of synapse-related genes and downregulation of ribosome- and mitochondria-related genes compared with vehicle-treated WT mice. They also showed a transcriptomic pattern largely opposite that observed in ASD (reverse-ASD pattern), based on ASD-related/risk genes and cell-type-specific genes. In memantine-treated Shank2-KO mice, chromatin-related genes were upregulated; mitochondria, extracellular matrix (ECM), and actin-related genes were downregulated; and the reverse-ASD pattern was weakened compared with that in vehicle-treated Shank2-KO mice. In WT mice, memantine treatment, which does not alter NMDAR function, upregulated synaptic genes and downregulated ECM genes; memantine-treated WT mice also exhibited a reverse-ASD pattern. Therefore, early chronic treatment of Shank2-KO mice with memantine alters expression of chromatin, mitochondria, ECM, actin, and ASD-related genes.

SUBMITTER: Yoo YE 

PROVIDER: S-EPMC8477010 | biostudies-literature | 2021

REPOSITORIES: biostudies-literature

altmetric image

Publications

Early Chronic Memantine Treatment-Induced Transcriptomic Changes in Wild-Type and <i>Shank2</i>-Mutant Mice.

Yoo Ye-Eun YE   Lee Seungjoon S   Kim Woohyun W   Kim Hyosang H   Chung Changuk C   Ha Seungmin S   Park Jinsu J   Chung Yeonseung Y   Kang Hyojin H   Kim Eunjoon E  

Frontiers in molecular neuroscience 20210914


Shank2 is an excitatory postsynaptic scaffolding protein strongly implicated in autism spectrum disorders (ASDs). <i>Shank2</i>-mutant mice with a homozygous deletion of exons 6 and 7 (<i>Shank2</i>-KO mice) show decreased NMDA receptor (NMDAR) function and autistic-like behaviors at juvenile [∼postnatal day (P21)] and adult (>P56) stages that are rescued by NMDAR activation. However, at ∼P14, these mice show the opposite change - increased NMDAR function; moreover, suppression of NMDAR activity  ...[more]

Similar Datasets

| S-EPMC9612946 | biostudies-literature
2021-10-06 | GSE171931 | GEO
| S-EPMC8226033 | biostudies-literature
2021-04-20 | GSE97896 | GEO
| PRJNA721409 | ENA
| S-EPMC11259993 | biostudies-literature
2021-05-27 | GSE168211 | GEO
| S-EPMC6638280 | biostudies-literature
| PRJNA383150 | ENA
| S-EPMC8936588 | biostudies-literature